Taro Pharmaceutical
TARO
#5314
Rank
S$2.06 B
Marketcap
S$54.98
Share price
0.00%
Change (1 day)
6.37%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): S$0.82

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is S$1.56. In 2021 the company made an earnings per share (EPS) of S$0.05118 an increase over its 2020 EPS that were of S-$10.12.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$0.82
2021S$0.05118-100.51%
2020S-$10.12-222.45%
2019S$8.27-18.02%
2018S$10.0853.01%
2017S$6.59-55.95%
2016S$14.96-13.41%
2015S$17.2736.92%
2014S$12.6237.71%
2013S$9.1621.15%
2012S$7.5644.15%
2011S$5.25175.17%
2010S$1.91-48.8%
2009S$3.72
2005S$0.03839-91.89%
2004S$0.47-82.55%
2003S$2.7135.9%
2002S$2.0039.29%
2001S$1.43140.86%
2000S$0.5969.09%
1999S$0.35139.13%
1998S$0.1564.29%
1997S$0.08957-36.36%
1996S$0.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.55 447.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.72 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97-37.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.27-18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.68 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$0.81-48.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel